Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Patent holders need to form an association and then hirer lobbyists to protect

looking at this stock over just the last few months, it seems that there is a a fairly presistent effort to sell into the lowest bid of the end of the day to keep the stock price low which is offset only occasionally by lackluster attempts to prop it up with silly trades of a few hundred shares. (today provided yet another example)

These end of day sales cannot all be by long term holders or can they? Are they just end of year loss taking is hopes of better news and a repurchase in the future?

Only 4 millon shares (~$200K) turned over in the last 30 days as the company value slid downward 20% (~$5MM) is an interesting (even impressive) ratio

Wonder what price this will bottom out at before the next hopefully positive annoucment. 3.5 cents again?

Share
New Message
Please login to post a reply